Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -8.21
- Piotroski Score 2.00
- Grade Speculative Buy
- Symbol (MLSS)
- Company Milestone Scientific Inc.
- Price $0.70
- Changes Percentage (3.15%)
- Change $0.02
- Day Low $0.65
- Day High $0.72
- Year High $1.10
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/27/2025
- Fiscal Year End N/A
- Average Stock Price Target $4.00
- High Stock Price Target $4.00
- Low Stock Price Target $4.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.10
- Trailing P/E Ratio -7.3
- Forward P/E Ratio -7.3
- P/E Growth -7.3
- Net Income $-6,929,104
Income Statement
Quarterly
Annual
Latest News of MLSS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Milestone Scientific Inc (MLSS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
International dental sales saw a 57% increase. Positive discussions with pain clinics and hospitals led to a partnership with Axial Biologics and the launch of a pricing strategy. Balancing sales grow...
By Yahoo! Finance | 5 days ago
